IL1B and hydrops fetalis: On the other hand, a number of in vitro studies have analyzed IL-1 and IL-33 signaling in the context of HF, hinting at promising new therapeutic approaches aiming at enhancing IL-33 signaling [36,53,54] or inhibiting IL-1 signaling, e.g., with neutralizing antibodies.